Deutetrabenazine ( DrugBank: Deutetrabenazine )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
8ハンチントン病3

8. ハンチントン病


臨床試験数 : 242 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04713982
(ClinicalTrials.gov)
November 19, 20216/1/2021Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington DiseaseImpact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington DiseaseHuntington DiseaseDrug: DeutetrabenazineVanderbilt University Medical CenterTeva Branded Pharmaceutical Products R&D, Inc.Recruiting18 YearsN/AAll30Phase 2/Phase 3United States
2NCT04301726
(ClinicalTrials.gov)
September 1, 202013/2/2020Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated With HDEfficacy of Deutetrabenazine in Huntington's Disease Patients With Dysphagia: A Randomised, Placebo-controlled Pilot StudyHuntington DiseaseDrug: Deutetrabenazine Oral Tablet [Austedo];Drug: Placebo oral tabletFundacion Huntington Puerto RicoNULLNot yet recruiting21 YearsN/AAll48Phase 1NULL
3NCT04071639
(ClinicalTrials.gov)
March 12, 202026/8/2019Symptomatic Therapy for Patients With Huntington's DiseaseNon-randomized Control Clinical Trial to Evaluate the Efficacy and Safety of Symptomatic Drug Therapy for Mild to Moderate Huntington's Disease PatientsHuntington DiseaseDrug: Haloperidol 2Mg Tab;Drug: Risperidone 1Mg Tab;Drug: Zoloft 50Mg Tablet;Drug: Idebenone;Drug: Deutetrabenazine Oral Tablet [Austedo]Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNULLRecruitingN/AN/AAll60Phase 1China